CSG's Record €18 Billion Backlog Meets a Harder Profitability Test

J.P. Morgan stripped CSG of its "Overweight" rating on Thursday and slashed the price target from €27.50 to €12, a move that lands just as the defense group's order book sits at a record €18 billion. The downgrade, reported by media outlets, reflects mounting concern over the future profitability of medium- and large-caliber ammunition and the company's reduced full-year outlook. Shifting demand and procurement shaped by drone warfare could weigh on earnings more heavily than previously anticipated.

The rating action followed a Wednesday guidance cut that put the profit question front and center. CSG now expects an operating EBIT margin of roughly 21% for full-year 2026, down from the 24–25% it had previously projected. Revenue guidance, by contrast, was reaffirmed at €7.4–7.6 billion. The uncertainty has therefore narrowed to a single issue: how much profit the expected volume can actually deliver.

A Mix Shift That Cuts Both Ways

Company statements point to two forces behind the margin reset. Customers are moving away from standard-range ammunition toward rounds with greater reach, and CSG is selling off standard-range stock at lower prices. On top of that, ramp-up phases for Land Systems programs carry thinner margins. The first nine months of 2026 told a mixed story on the top line: revenue reached €4.76 billion, up 6.1% year on year, even as third-quarter sales fell 11.7% to €1.51 billion.

The earnings picture is weaker still. Operating EBIT dropped 20.9% to €317 million in the third quarter of 2026, underscoring why the margin trajectory now takes precedence for investors. As long as price concessions and less profitable programs shape the business mix, additional volume can arrive alongside softer results.

Capital discipline adds another hurdle. CSG raised its net working capital target on Wednesday to below 35% of revenue, up from a prior ceiling of below 20%. A margin stabilization would carry far more conviction if capital intensity stays in check at the same time.

Canada Order and Army Program Offer a Path

Against that backdrop, the Canadian contract gives CSG a concrete foothold. Speer Ammunition, part of the company's The Kinetic Group, won a supply deal from Canada's Department of National Defence for up to 4.2 million rounds of 9mm Luger JHP ammunition, with a potential term of up to three years. The multi-year delivery horizon offers an additional sales channel at a moment when the earnings outlook has dimmed.

A second opportunity emerged in early November, when MSM North America was selected for a U.S. Army modernization program. Through the subsidiary, CSG may compete for individual awards within a five-year framework whose combined ceiling is roughly $4.2 billion. Selection opens the door to competition; a tangible business contribution only materializes if specific orders follow.

In the favorable scenario, the Speer contract adds revenue while the drag from discounted standard ammunition fades. Land Systems programs could improve profitability as their ramp-up progresses toward higher margins. Both developments would strengthen earnings quality — but only if CSG converts the added business into adequate operating returns.

What Investors Should Watch Next

Execution of the Canadian delivery contract is the nearest operational test, followed by possible individual awards under the American modernization framework. The link between contract progress and earnings development is what matters now. A more constructive view emerges if new business supports the margin and keeps capital binding contained. Should that connection stay weak, the existing earnings risks will outweigh the value of fresh order announcements.

For now, the confirmed revenue target and a stabilized margin at the lowered level keep a recovery in earnings quality a plausible scenario. Deepening price concessions or heavier drag from the business mix would erode that thesis. The record backlog is real; the question is how much of it reaches the bottom line.